Abstract
The STAT3 pathway promotes epithelial–mesenchymal transition, migration, invasion and metastasis in cancer. STAT3 upregulates the transcription of the key epithelial–mesenchymal transition transcription factor SNAIL in a DNA binding-independent manner. However, the mechanism by which STAT3 is recruited to the SNAIL promoter to upregulate its expression is still elusive. In our study, the lysine methylation binding protein L3MBTL3 is positively associated with metastasis and poor prognosis in female patients with breast cancer. L3MBTL3 also promotes epithelial–mesenchymal transition and metastasis in breast cancer. Mechanistic analysis reveals that L3MBTL3 interacts with STAT3 and recruits STAT3 to the SNAIL promoter to increase SNAIL transcription levels. The interaction between L3MBTL3 and STAT3 is required for SNAIL transcription upregulation and metastasis in breast cancer, while the methylated lysine binding activity of L3MBTL3 is not required for these functions. In conclusion, L3MBTL3 and STAT3 synergistically upregulate SNAIL expression to promote breast cancer metastasis.
Original language | English |
---|---|
Article number | 231 |
Journal | Nature Communications |
Volume | 16 |
Issue number | 1 |
DOIs | |
State | Published - Dec 2025 |
Bibliographical note
Publisher Copyright:© The Author(s) 2024.
Funding
We thank Prof. Mingyao Liu and Prof. Zhengfang Yi from East China Normal University for providing cFUGW-Flag-STAT3Y705F and cFUGW-Flag-STAT3-C plasmids. We thank Prof. Jian Luo from Tongji University for providing pcDNA3-HA-STAT3 plasmid. We thank Prof. Arrowsmith from University of North Carolina at Chapel Hill for providing L3MBTL3 full-length plasmid GFP-L3MBTL3. This study was supported by grants from the National Natural Science Foundation of China (82173044, J.F. and 81772817, J.L.), Shanghai Medical Leadership Program (2019LJ25, J.F.), Medical and Health Technology Public Relations Project of Shenzhen Longgang District Science and Technology Innovation Special Fund (LGKCYLWS2022001, J.F.), Special Program for Collaborative Innovation in Shanghai University of Medicine & Health Sciences (SPCI-17\u201015\u2010001, J.F.), and Key Subject Construction Project of Shanghai Municipal Commission of Health and Family Planning, China (ZK2019B29, J.F.). The results shown here are in part based upon data generated by the TCGA Research Network: \u201Chttps://www.cancer.gov/tcga.\u201D We thank Prof. Mingyao Liu and Prof. Zhengfang Yi from East China Normal University for providing cFUGW-Flag-STAT3 and cFUGW-Flag-STAT3-C plasmids. We thank Prof. Jian Luo from Tongji University for providing pcDNA3-HA-STAT3 plasmid. We thank Prof. Arrowsmith from University of North Carolina at Chapel Hill for providing L3MBTL3 full-length plasmid GFP-L3MBTL3. This study was supported by grants from the National Natural Science Foundation of China (82173044, J.F. and 81772817, J.L.), Shanghai Medical Leadership Program (2019LJ25, J.F.), Medical and Health Technology Public Relations Project of Shenzhen Longgang District Science and Technology Innovation Special Fund (LGKCYLWS2022001, J.F.), Special Program for Collaborative Innovation in Shanghai University of Medicine & Health Sciences (SPCI-17\u201015\u2010001, J.F.), and Key Subject Construction Project of Shanghai Municipal Commission of Health and Family Planning, China (ZK2019B29, J.F.). The results shown here are in part based upon data generated by the TCGA Research Network: \u201C https://www.cancer.gov/tcga .\u201D
Funders | Funder number |
---|---|
University of North Carolina Wilmington | |
Tongji University | |
East China Normal University | |
Medical and Health Technology Public Relations Project of Shenzhen Longgang District Science and Technology Innovation Special Fund | LGKCYLWS2022001 |
Shanghai Municipal Health and Family Planning Commission | ZK2019B29 |
Shanghai Municipal Health and Family Planning Commission | |
Shanghai Medical Leadership Program | 2019LJ25 |
National Natural Science Foundation of China (NSFC) | 82173044, 81772817 |
National Natural Science Foundation of China (NSFC) | |
Special Program for Collaborative Innovation in Shanghai University of Medicine & Health Sciences | SPCI-17‐15‐001 |
ASJC Scopus subject areas
- General Chemistry
- General Biochemistry, Genetics and Molecular Biology
- General Physics and Astronomy